# HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival

> **NCT07277192** · — · COMPLETED · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 562 (actual)

## Conditions studied

- Hepatecellular Carcinoma
- Liver Injury
- HAIC(Hepatic Artery Infusion Chemotherapy)
- TACE(Transcatheter Arterial Chemoembolization)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07277192
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 562 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07277192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07277192, "HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07277192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*